Zhejiang Gongdong Medical Technology Co., Ltd. Share Price

Equities

605369

CNE1000042X4

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
47.45 CNY +3.08% Intraday chart for Zhejiang Gongdong Medical Technology Co., Ltd. +10.02% -14.99%

Financials

Sales 2024 * 1.52B 210M 16.85B Sales 2025 * 1.98B 274M 21.93B Capitalization 5.34B 737M 59.06B
Net income 2024 * 308M 42.51M 3.4B Net income 2025 * 403M 55.62M 4.45B EV / Sales 2024 * 3.51 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 2.69 x
P/E ratio 2024 *
17.3 x
P/E ratio 2025 *
13.3 x
Employees 1,777
Yield 2024 *
3.75%
Yield 2025 *
5.06%
Free-Float 24.78%
More Fundamentals * Assessed data
Dynamic Chart
Zhejiang Gongdong Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Zhejiang Gongdong Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Gongdong Medical Technology Buys Land for 29.9 Million Yuan MT
Zhejiang Gongdong Medical Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhejiang Gongdong Medical Technology Co.,Ltd.(XSSC:605369) added to S&P Global BMI Index CI
Certain A Shares of Zhejiang Gongdong Medical Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 17-SEP-2023. CI
Zhejiang Gongdong Medical Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhejiang Gongdong Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhejiang Gongdong Medical Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Zhejiang Gongdong Medical Technology Registers Medical Devices Subsidiary MT
GD Medical Inc. announced that it has received $45 million in funding from Zhejiang Gongdong Medical Technology Co.,Ltd. CI
Zhejiang Gongdong Medical Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Gd Medical Inc. announced that it expects to receive $45 million in funding from Zhejiang Gongdong Medical Technology Co.,Ltd. CI
Zhejiang Gongdong Medical Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Zhejiang Gongdong Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day+3.08%
1 week+10.02%
Current month+5.96%
1 month+3.83%
3 months+2.62%
6 months-9.13%
Current year-14.99%
More quotes
1 week
42.30
Extreme 42.3
48.05
1 month
42.21
Extreme 42.21
49.29
Current year
34.08
Extreme 34.08
56.08
1 year
34.08
Extreme 34.08
64.15
3 years
34.08
Extreme 34.08
155.29
5 years
27.13
Extreme 27.1286
155.29
10 years
27.13
Extreme 27.1286
155.29
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 23/10/17
Director of Finance/CFO 40 30/09/17
Director/Board Member 41 23/10/17
Members of the board TitleAgeSince
Chairman 58 23/10/17
Chief Executive Officer 47 23/10/17
Director/Board Member 65 23/10/17
More insiders
Date Price Change Volume
26/04/24 47.45 +3.08% 507,235
25/04/24 46.03 +2.77% 393,105
24/04/24 44.79 +0.20% 287,300
23/04/24 44.7 +2.83% 391,334
22/04/24 43.47 +0.79% 280,100

End-of-day quote Shanghai S.E., April 25, 2024

More quotes
Zhejiang Gongdong Medical Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of disposable medical consumables. The Company's main products cover vacuum blood collection systems, laboratory testing consumables, body fluid collection consumables, medical care consumables and pharmaceutical packaging materials. Its products include disposable vacuum blood collection tubes, petri dishes, culture plates, cuvettes, pipette tips, disposable sterile sampling swabs, dispensers, dressing containers and others. The Company's products are applied in clinical diagnosis and nursing, scientific research and testing, pharmaceutical packaging and other fields. The Company distributes its products in the domestic market and to overseas markets, including many countries in North America, Asia, South America, Africa and Europe.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
47.45 CNY
Average target price
70 CNY
Spread / Average Target
+47.52%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 605369 Stock